By proceeding, you agree to our Terms of Use and Privacy Policy.
Motivated and experienced research scientist in the hematology/oncology research therapeutic area.
Talks About #drugdiscovery #cell
Preferred Locations #Northamerica
With 2023 on track to see further growth in the immuno-oncology field, the availability of tools that offers drug developers & researchers advantages that weren’t available to them even a few years ago is increasing rapidly.
